Inactive Instrument

News Fresenius Kabi Oncology Ltd

Equities

End-of-day quote NSE India S.E. Other stock markets
- ^INR	-

2016	AstraZeneca sells rights to anaesthetics for up to $770 million	RE
2015	Fresenius SE KGaA : Kabi sells German oncology compounding business	RE

AstraZeneca sells rights to anaesthetics for up to $770 million	09/16/09	RE
Fresenius SE KGaA : Kabi sells German oncology compounding business	16/15/16	RE
Fresenius Kabi Oncology Ltd : India revokes GSK cancer drug patent in latest Big Pharma blow	02/13/02	RE
Fresenius Kabi Oncology Ltd : India board revokes GSK patent on breast cancer drug Tykerb	02/13/02	RE

No results for this search